Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma. | BMC Cancer | 2022 | 35568824 | PubTator, text mining | PubMed |
| A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment. | J Clin Med | 2022 | 35566403 | PubTator, text mining | PubMed |
| Hypoxia as a Modulator of Inflammation and Immune Response in Cancer. | Cancers (Basel) | 2022 | 35565420 | PubTator, text mining | PubMed |
| Estrogens, Cancer and Immunity. | Cancers (Basel) | 2022 | 35565393 | PubTator, text mining | PubMed |
| Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma. | Cancers (Basel) | 2022 | 35565286 | PubTator, text mining | PubMed |
| The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma. | Cancers (Basel) | 2022 | 35565234 | PubTator, text mining | PubMed |
| Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma. | J Transl Med | 2022 | 35562760 | PubTator, text mining | PubMed |
| Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer. | Front Genet | 2022 | 35559045 | PubTator, text mining | PubMed |
| OX40 and 4-1BB delineate distinct immune profiles in sarcoma. | Oncoimmunology | 2022 | 35558159 | PubTator, text mining | PubMed |
| Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. | Oncoimmunology | 2022 | 35558158 | PubTator, text mining | PubMed |
| Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors. | Front Immunol | 2022 | 35558065 | PubTator, text mining | PubMed |
| Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. | Biomark Res | 2022 | 35550636 | PubTator, text mining | PubMed |
| Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back. | Front Immunol | 2022 | 35547736 | PubTator, text mining | PubMed |
| Fundamental immune-oncogenicity trade-offs define driver mutation fitness. | Nature | 2022 | 35545680 | PubTator, text mining | PubMed |
| Extricating human tumour immune alterations from tissue inflammation. | Nature | 2022 | 35545675 | PubTator, text mining | PubMed |
| New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials. | Int J Biol Sci | 2022 | 35541908 | PubTator, text mining | PubMed |
| Establishment of an age- and tumor microenvironment-related gene signature for survival prediction in prostate cancer. | Cancer Med | 2022 | 35535438 | PubTator, text mining | PubMed |
| Pharmacological targeting of the tumor-immune symbiosis in glioblastoma. | Trends Pharmacol Sci | 2022 | 35534356 | PubTator, text mining | PubMed |
| Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer. | Front Oncol | 2022 | 35530332 | PubTator, text mining | PubMed |
| The Significance of Tumor Microenvironment Score for Breast Cancer Patients. | Biomed Res Int | 2022 | 35528180 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=61